About: Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ) #

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ) # Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ) #
Creator	Hare, David Nicholls, Stephen Brown, Alex Inglis, Sally Nelson, Mark Redfern, Julie Clark, Robyn O'neil, Adrienne Astley, Carolyn Briffa, Tom Colquhoun, David Gallagher, Robyn Jelinek, Michael Tirimacco, Rosy Vale, Margarite
source	Elsevier; Medline; PMC
abstract	Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has introduced a major disruption to the delivery of routine health care across the world. This provides challenges for the use of secondary prevention measures in patients with established atherosclerotic cardiovascular disease (CVD). The aim of this Position Statement is to review the implications for effective delivery of secondary prevention strategies during the COVID-19 pandemic. Challenges The COVID-19 pandemic has introduced limitations for many patients to access standard health services such as visits to health care professionals, medications, imaging and blood tests as well as attendance at cardiac rehabilitation. In addition, the pandemic is having an impact on lifestyle habits and mental health. Taken together, this has the potential to adversely impact the ability of practitioners and patients to adhere to treatment guidelines for the prevention of recurrent cardiovascular events. Recommendations Every effort should be made to deliver safe ongoing access to health care professionals and the use of evidenced based therapies in individuals with CVD. An increase in use of a range of electronic health platforms has the potential to transform secondary prevention. Integrating research programs that evaluate the utility of these approaches may provide important insights into how to develop more optimal approaches to secondary prevention beyond the pandemic.
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.1016/j.hlc.2020.04.007
bibo:pmid	32473781
has license	els-covid
sha1sum (hex)	e565f22defc22187c3e7eec110b87b4d8b5110c2
schema:url	https://doi.org/10.1016/j.hlc.2020.04.007
resource representing a document's title	Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ) #
has PubMed Central identifier	PMC7192068
has PubMed identifier	32473781
schema:publication	Heart Lung Circ
resource representing a document's body	covid:e565f22defc22187c3e7eec110b87b4d8b5110c2#body_text
is schema:about of	named entity 'major' named entity 'During' named entity 'Australia' named entity 'pandemic' named entity 'Journal' named entity 'Prevention' named entity 'health care' named entity 'Secondary Prevention' named entity 'Cardiac Rehabilitation' named entity 'COVID-19 Pandemic' named entity 'CVD' named entity 'depression' named entity 'thought processes' named entity 'acute coronary syndrome' named entity 'antiplatelet' named entity 'psychosocial' named entity 'Secondary prevention' named entity 'respiratory complications' named entity 'health care insurance' named entity 'access to food' named entity 'secondary prevention' named entity 'smokers' named entity 'nicotine replacement therapy' named entity 'telehealth' named entity 'myocarditis' named entity 'blood pressure' named entity 'psychosocial' named entity 'activity trackers' named entity 'cardiovascular complications' named entity 'socioeconomic groups' named entity 'medication adherence' named entity 'risk factor' named entity 'COVID-19 virus' named entity 'poor nutrition' named entity 'COVID' named entity 'cost effectiveness' named entity 'social distancing' named entity 'medication adherence' named entity 'health care' named entity 'National Heart Foundation of Australia' named entity 'social distancing' named entity 'healthy diet' named entity 'mental health' named entity 'angiotensin-converting enzyme' named entity 'sequelae' named entity 'public policy' named entity 'blood pressure' named entity 'cardiac rehabilitation' named entity 'pharmacological' named entity 'morbidity' named entity 'chest pain' named entity 'Pharmacies' named entity 'health services' named entity 'COVID' named entity 'telehealth' named entity 'lifestyle change' named entity 'COVID' named entity 'healthy eating' named entity 'health care' named entity 'cardiac rehabilitation' named entity 'venous thromboembolism' named entity 'evidence-based' named entity 'Social distancing' named entity 'mental health' named entity 'cardiovascular events' named entity 'e-health' named entity 'sequelae'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software